Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evidence for Biologic Drug Modifying Anti-Rheumatoid Drugs and Association with Cardiovascular Disease Risk Mitigation in Inflammatory Arthritis

Rheumatic Disease Clinics of North America(2022)10.1016/j.rdc.2022.08.005Source: DataRank Database

Evidence for Biologic Drug Modifying Anti-Rheumatoid Drugs and Association with Cardiovascular Disease Risk Mitigation in Inflammatory Arthritis is a research paper published in Rheumatic Disease Clinics of North America (2022). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.77)OA: greenTopics (25)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Katherine P. Liao ORCID,Brittany Weber ORCID

Live enrichment

PubMed:36424023 PMC:PMC10250044 OpenAlex:https://openalex.org/W4309503093

NIH

Grant: K23 HL159276-01

American Heart Association

Grant: 21CDA851511

American Heart Association

Grant: R01 HL127118

NHLBI NIH HHS

Grant: K23 HL159276

FWCI

0.77

Citation Percentile

0.7%

Citation Trend

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10250044/pdf/nihms-1904443.pdf

BRONZEhttps://www.sciencedirect.com/science/article/am/pii/S0889857X22000746

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10250044/pdf/nihms-1904443.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0889857X22000746?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0889857X22000746?httpAccept=text/plain

Fields of Study

Rheumatoid Arthritis Research and TherapiesSpondyloarthritis Studies and TreatmentsAutoimmune and Inflammatory Disorders ResearchMedicine

MeSH Terms

Arthritis, RheumatoidBiological ProductsCardiovascular DiseasesHumansProspective StudiesAntirheumatic Agents

Keywords

MedicineRheumatoid arthritisPsoriatic arthritisDrugDiseaseIntensive care medicineBiologic AgentsInflammatory arthritisArthritisInternal medicinePharmacologyInflammationSpondylarthritiscardiovascularDisease-modifying Antirheumatic Drug (Dmard)

Sustainable Development Goals

SDG 0: Good health and well-being